SC
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| REPRESENT : REPresentativeness of RESearch data obtained through the 'General Informed ConsENT' | BMC medical ethics |  | 2023 | 157 | 191 | ||
| Patient engagement in clinical research : Geneva University Hospitals’ model | Regulatory affairs watch | | 2021 | 26 | 116 | ||
| Macrophages and liposomes in inflammatory disease: friends or foes? | International journal of pharmaceutics |  | 2011 | 466 | 0 | ||
| AS601245, a c-Jun NH2-terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils | British journal of pharmacology | | 2008 | 480 | 0 | ||
| Noradrenaline and dopamine elevations in the rat prefrontal cortex in spatial working memory | The Journal of neuroscience | | 2005 | 513 | 0 | ||
| The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity | The Journal of neuroscience | | 2005 | 473 | 0 | ||
| Control of death receptor and mitochondrial-dependent apoptosis by c-Jun N-terminal kinase in hippocampal CA1 neurones following global transient ischaemia | Journal of neurochemistry | | 2005 | 438 | 0 | ||
| AS601245 (1,3-benzothiazol-2-yl (2-[[2-(3-pyridinyl) ethyl] amino]-4 pyrimidinyl) acetonitrile): a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties | The Journal of pharmacology and experimental therapeutics | | 2004 | 494 | 0 | ||
| Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats | British journal of pharmacology | | 2004 | 452 | 0 | ||
| Bidirectional modulation of spatial working memory by ethanol | Alcoholism, clinical and experimental research | | 2002 | 437 | 0 | ||
| Increased extracellular glutamate in rat prefrontal cortex: movement artifact contribution | Brain research | | 2001 | 459 | 0 |
